MMedication Read More Some patients experience mental health backlash from GLP-1 medicationsFebruary 3, 2026 The use of GLP-1 weight loss medications is skyrocketing in the United States, more than doubling since 2024.…
FFitness Read More 75 Hard viral fitness challenge sparks expert warnings about sustainabilityFebruary 1, 2026 NEWYou can now listen to Fox News articles! An extreme, all-or-nothing fitness regimen is going viral again as…
MMedication Read More Quitting Ozempic Is a Risky Proposition – NewserJanuary 31, 2026 Quitting Ozempic Is a Risky Proposition NewserExclusive | The rise of ‘agonorexia’: GLP-1s feeding dangerous food and body image…
MMedication Read More The rise of GLP-1 prescription drugsJanuary 30, 2026 QUINCY (WGEM) – How Americans spend their dollars can depend on lifestyle, priorities, or even the number of…
MMedication Read More US FDA Approves First Daily Oral GLP‑1 Treatment for Weight Management, Showing Comparable Results to Injectable TherapyJanuary 29, 2026 The US Food and Drug Administration (FDA) has approved Novo Nordisk’s new once-daily pill for weight management, designed…
FFitness Read More Alison Hammond’s 11 stone weight loss secret revealed after one ‘drastic’ changeJanuary 27, 2026 Alison Hammond looks incredible after undergoing a serious fitness journey in recent yearsNicola Croal Trends, Showbiz and Lifestyle…
MMedication Read More How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q4 Results?January 26, 2026 Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
NNutrition Read More Big Food has devoured British farmersJanuary 23, 2026 Britain’s food system is a remarkable exercise in trusting strangers. We hope that the people who produce, transport…
MMedication Read More 6 New Weight Loss Drugs That Could Dethrone OzempicJanuary 22, 2026 The arrival of semaglutide and similar GLP-1 drugs in recent years has ushered in a new era of…
MMedication Read More Weight loss drug Wegovy to be subsidised for Australians with severe obesityJanuary 16, 2026 An Ozempic-like medication is set to be listed on the Pharmaceutical Benefits Scheme shortly, saving patients with “severe”…
MMedication Read More How Will Mounjaro and Zepbound Sales Aid LLY’s Upcoming Q4 Results?January 16, 2026 Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its…
MMedication Read More Weight returns four times faster after stopping weight-loss drugsJanuary 14, 2026 When people stop taking the new generation of weight-loss drugs, they pile back the kilos four times faster…